Education
About Us
Working with TipRanks
Follow Us
Spectral AI (MDAI)
NASDAQ:MDAI
MDAI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.01 - $3.25
Previous CloseN/A
Volume689.87K
Average Volume (3M)475.51K
Market Cap
$67.63M
Enterprise Value$62.17M
Total Cash (Recent Filing)$10.52M
Total Debt (Recent Filing)$9.65M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Nov 17, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding26,730,988
10 Day Avg. Volume655,310
30 Day Avg. Volume475,512
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue2.26
Enterprise Value/Gross Profit5.04
Enterprise Value/Ebitda-2.81
Forecast
1Y Price Target
$4.33Price Target Upside76.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Commercialization And Regulatory ProgressThe company hopes to gain approval with a Class II medical device designation and initiate commercialization in mid-2026.
Product Development And Future ApplicationsMDAI's miniaturized version of DeepView is progressing and expected to be ready for military use, showing potential for future applications.
Regulatory Filings And Market OpportunitiesMDAI submitted regulatory filings to the FDA for the Burn indication, with clearance expected, which could open new opportunities.
Bears Say
Cash Position And FundingSpectral AI ended 2Q25 with cash and cash equivalents of $10.5M, which is believed to be sufficient cash runway to fund operations into 2Q26.
Financial PerformanceFor 2Q25, the company reported revenues of $5.1M and a net loss of $0.31 per diluted share, compared to consensus estimates revenues of $5.5M and a net loss of $0.07.
Spectral AI News
MDAI FAQ
What was Spectral AI’s price range in the past 12 months?
Spectral AI lowest stock price was $1.01 and its highest was $3.25 in the past 12 months.
What is Spectral AI’s market cap?
Spectral AI’s market cap is $67.63M.
When is Spectral AI’s upcoming earnings report date?
Spectral AI’s upcoming earnings report date is Nov 17, 2025 which is in 37 days.
How were Spectral AI’s earnings last quarter?
Spectral AI released its earnings results on Aug 12, 2025. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.074 by -$0.236.
Is Spectral AI overvalued?
According to Wall Street analysts Spectral AI’s price is currently Undervalued.
Does Spectral AI pay dividends?
Spectral AI does not currently pay dividends.
What is Spectral AI’s EPS estimate?
Spectral AI’s EPS estimate is -0.08.
How many shares outstanding does Spectral AI have?
Spectral AI has 26,730,988 shares outstanding.
What happened to Spectral AI’s price movement after its last earnings report?
Spectral AI reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.074. Following the earnings report the stock price went down -4.933%.
Which hedge fund is a major shareholder of Spectral AI?
Currently, no hedge funds are holding shares in MDAI
Spectral AI Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.33 (76.73% Upside)
$4.33 (76.73% Upside)
Blogger Sentiment
Bullish
MDAI Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 100.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.8%
Last 30 Days ▲ 27.5%
Last 30 Days ▲ 27.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
120.72%
12-Months-Change
Fundamentals
Return on Equity
256.43%
Trailing 12-Months
Asset Growth
15.20%
Trailing 12-Months
Company Description
Spectral AI
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
MDAI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in FDA submission and financial strengthening, despite facing challenges in decreased R&D revenue and increased net loss for the quarter. The progress made in operational efficiencies and financial positioning suggests a cautiously optimistic outlook.View all MDAI earnings summariesMDAI Stock 12 Month Forecast
Average Price Target
$4.33
▲(76.73% Upside)
Technical Analysis
iCAD
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vicarious Surgical
―
Hyperfine
―
Ownership Overview
10.16% Insiders
3.44% Mutual Funds
6.86% Other Institutional Investors
77.52% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---